{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T21:58:12Z","timestamp":1780610292113,"version":"3.54.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1124\/dmd.113.051052","type":"journal-article","created":{"date-parts":[[2013,5,3]],"date-time":"2013-05-03T06:24:26Z","timestamp":1367562266000},"page":"1442-1449","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Integrated Approach of In Vivo and In Vitro Evaluation of the Involvement of Hepatic Uptake Organic Anion Transporters in the Drug Disposition in Rats Using Rifampicin as an Inhibitor"],"prefix":"10.1016","volume":"41","author":[{"given":"Tomoki","family":"Imaoka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Mikkaichi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakazu","family":"Hirouchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Okudaira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Izumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.113.051052_bib1","first-page":"640","article-title":"Biotransformation of cerivastatin in mice, rats, and dogs in vivo","volume":"26","author":"Boberg","year":"1998","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.113.051052_bib2","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1023\/A:1018943613122","article-title":"Physiological parameters in laboratory animals and humans","volume":"10","author":"Davies","year":"1993","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.113.051052_bib3","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/0006-2952(95)00045-2","article-title":"Rifampicin enhances anti-cancer drug accumulation and activity in multidrug-resistant cells","volume":"49","author":"Fardel","year":"1995","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.113.051052_bib4","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1248\/bpb.30.556","article-title":"Down-regulation of hepatic transporters for BSP in rats with indomethacin-induced intestinal injury","volume":"30","author":"Fujiyama","year":"2007","journal-title":"Biol Pharm Bull"},{"key":"10.1124\/dmd.113.051052_bib5","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrd3028","article-title":"Membrane transporters in drug development","volume":"9","author":"Giacomini","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/dmd.113.051052_bib6","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1124\/dmd.111.039842","article-title":"The impact of hepatic uptake on the pharmacokinetics of organic anions","volume":"39","author":"Gardiner","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.113.051052_bib7","series-title":"Guide for the Care and Use of Laboratory Animals","year":"1996"},{"key":"10.1124\/dmd.113.051052_bib8","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0163-7258(96)00184-2","article-title":"Prediction of in vivo drug metabolism in the human liver from in vitro metabolism data","volume":"73","author":"Iwatsubo","year":"1997","journal-title":"Pharmacol Ther"},{"key":"10.1124\/dmd.113.051052_bib9","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1742-7843.2005.pto_157.x","article-title":"Metabolism of repaglinide by CYP2C8 and CYP3A4 in vitro: effect of fibrates and rifampicin","volume":"97","author":"Kajosaari","year":"2005","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1124\/dmd.113.051052_bib10","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1124\/dmd.107.016162","article-title":"Role of transporters in the disposition of the selective phosphodiesterase-4 inhibitor (+)-2-[4-([2-(benzo[1,3]dioxol-5-yloxy)-pyridine-3-carbonyl]-amino-methyl)-3-fluoro-phenoxy]-propionic acid in rat and human","volume":"35","author":"Kalgutkar","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.113.051052_bib11","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1476-5381.2009.00430.x","article-title":"Impact of OATP transporters on pharmacokinetics","volume":"158","author":"Kalliokoski","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1124\/dmd.113.051052_bib12","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1124\/dmd.105.009076","article-title":"Pharmacokinetics of atorvastatin and its hydroxy metabolites in rats and the effects of concomitant rifampicin single doses: relevance of first-pass effect from hepatic uptake transporters, and intestinal and hepatic metabolism","volume":"34","author":"Lau","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.113.051052_bib13","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1080\/00498250210144820","article-title":"Pharmacokinetics and disposition of rosuvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in rat","volume":"32","author":"Nezasa","year":"2002","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.113.051052_bib14","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1124\/dmd.107.019455","article-title":"Prediction of the pharmacokinetics of atorvastatin, cerivastatin, and indomethacin using kinetic models applied to isolated rat hepatocytes","volume":"36","author":"Paine","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.113.051052_bib15","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1124\/dmd.108.025544","article-title":"Long-lasting inhibition of the transporter-mediated hepatic uptake of sulfobromophthalein by cyclosporin a in rats","volume":"37","author":"Shitara","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.113.051052_bib16","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1124\/dmd.106.014464","article-title":"Use of hepatocytes to assess the contribution of hepatic uptake to clearance in vivo","volume":"35","author":"Soars","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.113.051052_bib17","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00534-003-0872-5","article-title":"Comparison of urinary excretion of pravastatin and temocapril in bile duct-ligated rats and Eisai hyperbilirubinemic rats (EHBR)","volume":"11","author":"Takada","year":"2004","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"10.1124\/dmd.113.051052_bib18","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1053\/jhep.2002.34133","article-title":"Interactions of rifamycin SV and rifampicin with organic anion uptake systems of human liver","volume":"36","author":"Vavricka","year":"2002","journal-title":"Hepatology"},{"key":"10.1124\/dmd.113.051052_bib19","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1124\/dmd.109.030254","article-title":"Investigation of the rate-determining process in the hepatic elimination of HMG-CoA reductase inhibitors in rats and humans","volume":"38","author":"Watanabe","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.113.051052_bib20","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1124\/dmd.107.019398","article-title":"Cellular accumulation of cholyl-glycylamido-fluorescein in sandwich-cultured rat hepatocytes: kinetic characterization, transport mechanisms, and effect of human immunodeficiency virus protease inhibitors","volume":"36","author":"Ye","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.113.051052_bib21","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1124\/mol.108.046458","article-title":"Targeted disruption of murine organic anion-transporting polypeptide 1b2 (Oatp1b2\/Slco1b2) significantly alters disposition of prototypical drug substrates pravastatin and rifampin","volume":"74","author":"Zaher","year":"2008","journal-title":"Mol Pharmacol"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009095562409754X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009095562409754X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.113.051052","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T19:09:37Z","timestamp":1739905777000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009095562409754X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":21,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S009095562409754X"],"URL":"https:\/\/doi.org\/10.1124\/dmd.113.051052","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrated Approach of In Vivo and In Vitro Evaluation of the Involvement of Hepatic Uptake Organic Anion Transporters in the Drug Disposition in Rats Using Rifampicin as an Inhibitor","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.113.051052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2013 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}